A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05412979. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Crossover, Phase 2 Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
ST-1891-201 is a multicenter, randomized, double-blind, partial crossover, Phase 2 study evaluating the safety and efficacy of hormone replacement therapy with ST-1891 compared to levothyroxine in patients with primary hypothyroidism.
Study identification
- NCT ID
- NCT05412979
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 490 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 29, 2022 (Actual)
- Primary completion
- Oct 4, 2023 (Actual)
- Completion
- Oct 4, 2023 (Actual)
- Last update posted
- Aug 26, 2024
2022 – 2023
United States locations
- U.S. sites
- 39
- U.S. states
- 17
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sention Investigational Site | Greenbrae | California | 94904 | — |
| Sention Investigational Site | Newhall | California | 91321 | — |
| Sention Investigational Site | Denver | Colorado | 80246 | — |
| Sention Investigational Site | Fort Lauderdale | Florida | 33312 | — |
| Sention Investigational Site | Jacksonville | Florida | 32258 | — |
| Sention Investigational Site | New Port Richey | Florida | 34652 | — |
| Sention Investigational Site | Palm Harbor | Florida | 34684 | — |
| Sention Investigational Site | Atlanta | Georgia | 30318 | — |
| Sention Investigational Site | Lawrenceville | Georgia | 30046 | — |
| Sention Investigational Site | Roswell | Georgia | 30076 | — |
| Sention Investigational Site | Evergreen Park | Illinois | 60805 | — |
| Sention Investigational Site | Newburgh | Indiana | 47630 | — |
| Sention Investigational Site | South Bend | Indiana | 46617 | — |
| Sention Investigational Site | Ankeny | Iowa | 50023 | — |
| Sention Investigational Site | Louisville | Kentucky | 40213 | — |
| Sention Investigational Site | Dearborn | Michigan | 48126 | — |
| Sention Investigational Site | Chesterfield | Missouri | 63017 | — |
| Sention Investigational Site | Jefferson City | Missouri | 65109 | — |
| Sention Investigational Site | Staten Island | New York | 10301 | — |
| Sention Investigational Site | Cary | North Carolina | 27518 | — |
| Sention Investigational Site | Greenville | North Carolina | 27834 | — |
| Sention Investigational Site | Hickory | North Carolina | 28601 | — |
| Sention Investigational Site | Morehead City | North Carolina | 28557 | — |
| Sention Investigational Site | Raleigh | North Carolina | 27609 | — |
| Sention Investigational Site | Rocky Mount | North Carolina | 27804 | — |
| Sention Investigational Site | Salisbury | North Carolina | 28144 | — |
| Sention Investigational Site | Wilmington | North Carolina | 28401 | — |
| Sention Investigational Site | Mt. Pleasant | South Carolina | 29464 | — |
| Sention Investigational Site | Bristol | Tennessee | 37620 | — |
| Sention Investigational Site | Chattanooga | Tennessee | 37411 | — |
| Sention Investigational Site | Memphis | Tennessee | 38133 | — |
| Sention Investigational Site | Austin | Texas | 78731 | — |
| Sention Investigational Site | Austin | Texas | 78749 | — |
| Sention Investigational Site | Benbrook | Texas | 76132 | — |
| Sention Investigational Site | Live Oak | Texas | 78233 | — |
| Sention Investigational Site | Round Rock | Texas | 78681 | — |
| Sention Investigational Site | Webster | Texas | 77598 | — |
| Sention Investigational Site | Virginia Beach | Virginia | 23462 | — |
| Sention Investigational Site | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05412979, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 26, 2024 · Synced Nov 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.